• Clinical Evidence

Improving IV Insulin Administration in a Community Hospital

Setting: 207-bed not-for-profit community hospital.

Objective

This study compares glycemic outcomes with a traditional paper protocol to a computerized glucose management system (EndoTool) for patients receiving intravenous insulin.

Setting

207-bed not-for-profit community hospital.

Results

  • Incidence of hypoglycemia <70 mg/dL decreased 89% with EndoTool, from 6.9% to 0.76% of blood glucose readings
  • Incidence of hypoglycemia <40 mg/dL was .01% of blood glucose readings with EndoTool.
  • Incidence of hyperglycemia >180 mg/dL decreased 54% with EndoTool, from 26.3% to 12.1% of blood glucose readings, and incidence >300 mg/dL decreased 68%, from 4.9% to 1.55% of blood glucose readings.
  • Percentage of blood glucose readings in target increased 35% with EndoTool, from 63.6% to 86.1%.

Conclusions

Use of a computerized glucose management system (EndoTool) achieves substantially better glucose control than a traditional paper protocol, with lower incidence of both hypoglycemia and hyperglycemia and a greater percentage of blood glucose readings in target.
Objective

This study compares glycemic outcomes with a traditional paper protocol to a computerized glucose management system (EndoTool) for patients receiving intravenous insulin.

Setting

207-bed not-for-profit community hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL decreased 89% with EndoTool, from 6.9% to 0.76% of blood glucose readings
  • Incidence of hypoglycemia <40 mg/dL was .01% of blood glucose readings with EndoTool.
  • Incidence of hyperglycemia >180 mg/dL decreased 54% with EndoTool, from 26.3% to 12.1% of blood glucose readings, and incidence >300 mg/dL decreased 68%, from 4.9% to 1.55% of blood glucose readings.
  • Percentage of blood glucose readings in target increased 35% with EndoTool, from 63.6% to 86.1%.
Conclusions

Use of a computerized glucose management system (EndoTool) achieves substantially better glucose control than a traditional paper protocol, with lower incidence of both hypoglycemia and hyperglycemia and a greater percentage of blood glucose readings in target.

References

Authors

Michael Magee.

Source

Published in Journal of Visualized Experiments (Medicine), Issue 64, pe3705.

Year

2012

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This study compares glycemic outcomes with a traditional paper protocol to a computerized glucose management system (EndoTool) for patients receiving intravenous insulin.

Setting

207-bed not-for-profit community hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL decreased 89% with EndoTool, from 6.9% to 0.76% of blood glucose readings
  • Incidence of hypoglycemia <40 mg/dL was .01% of blood glucose readings with EndoTool.
  • Incidence of hyperglycemia >180 mg/dL decreased 54% with EndoTool, from 26.3% to 12.1% of blood glucose readings, and incidence >300 mg/dL decreased 68%, from 4.9% to 1.55% of blood glucose readings.
  • Percentage of blood glucose readings in target increased 35% with EndoTool, from 63.6% to 86.1%.
Conclusions

Use of a computerized glucose management system (EndoTool) achieves substantially better glucose control than a traditional paper protocol, with lower incidence of both hypoglycemia and hyperglycemia and a greater percentage of blood glucose readings in target.

References

Authors

Michael Magee.

Source

Published in Journal of Visualized Experiments (Medicine), Issue 64, pe3705.

Year

2012

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.
Image
  • Clinical Evidence

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
By submitting this form, you consent to the processing of your personal information, including sensitive personal information you provide, in accordance with the Monarch Medical Technologies Privacy Notice.